XBiotech Inc. (XBIT) Free cash flow 2016–2025
XBiotech Inc. (XBIT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$40.2MFY2025 · since FY2016: -$50.8M → -$40.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$40.2M | -24.6% |
| FY2024 | -$32.3M | -69.1% |
| FY2023 | -$19.1M | -23.9% |
| FY2022 | -$15.4M | -123.4% |
| FY2021 | $65.9M | +195.7% |
| FY2020 | -$68.9M | -272.8% |
| FY2019 | -$18.5M | -10.9% |
| FY2018 | -$16.7M | +52.5% |
| FY2017 | -$35.1M | +30.9% |
| FY2016 | -$50.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More XBIT financial trends
XBIT RevenueXBIT Net incomeXBIT Net marginXBIT Gross profitXBIT Gross marginXBIT Operating incomeXBIT Operating marginXBIT Operating cash flowXBIT Capital expendituresXBIT Return on equityXBIT Stock buybacksXBIT Dividends paidXBIT Total assetsXBIT Total liabilitiesXBIT Shareholders’ equityXBIT overview →